Pharma Pulse 4/12/24: Kenvue Revamps Cyber Tools After Spinoff From J&J, Long-Term Clinical Benefits of Cancer Treatments Granted Accelerated Approval & more

Evaluating the Long-Term Clinical Benefit of Cancer Treatments Granted Accelerated Approval

A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs.

Talking About the Generations: The Health and Healthcare of Boomers, Gen Xers, Millennials and Gen Zers. Part 1, The Boomers

Tne Boomers (1946–1964): Active but aging

Kenvue Revamps Cyber Tools After Spinoff From J&J

The consumer-health company saw a surge in scams targeting employees around the time of its separation from Johnson & Johnson last year

Vetster Launches The Pet Friendly Workplace Certification

Certification program recognizes pet-inclusive employers building safe and healthy work environments for pet owners and their animals

@US_FDA on X:

"Thanks to Congress’ investment in the Human Genome Project decades ago, many of the approximately 10,000 rare diseases, which impact at least 30 million Americans, can now be treated with new gene-editing and gene therapy technologies." -- @DrCaliff_FDA

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs